Britain’s medicines regulator said four prescription-only Zantac medicines, including a syrup, an injection and tablets in 150 and 300 milligram doses, would be recalled.
Over-the-counter Zantac products are produced by a different company.
The decision is “precautionary” as health regulators in the U.S. and U.K. continue to review the safety of products with ranitidine, a drug that reduces stomach acid.
More articles on pharmacy:
Telemedicine startup to open first brick-and-mortar pharmacy
Top 10 pharmacy stories in September
Novant Health to open health clinics inside Walgreens
